News

News
In the media

Inside Johnson & Johnson’s Nonstop Hunt for a Coronavirus Vaccine

Read full story
In the media

Driving Innovation In UK Life Sciences

Read full story
Partner news

Vor Biopharma Closes $110 Million Series B Financing

Read full story
Partner news

CVRx Raises $50 Million in New Equity Financing

Read full story
In the media

Investing in innovation – new digital approaches for a new decade

Read full story
Other news

X-Vax Technology Raises $56 Million in Upsized Series A Financing to Advance Lead Herpes Vaccine Program

Read full story
Press release

Janssen Korea Ltd. and Johnson & Johnson Innovation Announce Launch of Seoul Innovation QuickFire Challenge in Smart Healthcare in Collaboration with Seoul Metropolitan Government and Korea Health Industry Development Institute

Read full story
Other news

Future of healthcare discussions held at Health Horizons in Cambridge

Read full story
Other news

BioTarget Competition: Speeding up the Race to Beat Cancer

Read full story
Press release

Johnson & Johnson Innovation Recognizes Women in STEM2D Joint Project with Griffith University

Read full story
JNJ Press releases

Johnson & Johnson Innovation Opens JLABS @ Shanghai in Collaboration with Shanghai Pharma Engine Company Ltd.

Read full story
Partner news

Provention Bio Announces Closing of Upsized Initial Public Offering

Read full story
Partner news

Asceneuron's Tau Modifier ASN120290 Receives Orphan Drug Designation for Progressive Supranuclear Palsy From the FDA

Read full story
JNJ Press releases

EUSA PHARMA ANNOUNCES ACQUISITION OF GLOBAL RIGHTS TO SYLVANT® (SILTUXIMAB) FROM JANSSEN SCIENCES IRELAND UC FOR $115 MILLION

Read full story
Partner news

Cue Health Completes $45MM Series B Financing

Read full story